Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +0.88% | +3.60% | -13.53% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.53% | 35.64M | |
-40.58% | 2.95B | |
+18.54% | 1.88B | |
-2.22% | 1.63B | |
+33.88% | 1.34B | |
-16.73% | 959M | |
-22.64% | 888M | |
+7.29% | 842M | |
-25.41% | 623M | |
+10.85% | 513M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Co-Diagnostics Receives $1.2 Million in New Funds From National Institutes of Health